Cisco Systems, Inc. (CSCO)
After hours:
| Previous close | 42.93 |
| Open | 43.44 |
| Bid | 44.05 x 4000 |
| Ask | 44.07 x 4000 |
| Day's range | 43.24 - 44.22 |
| 52-week range | 41.02 - 64.29 |
| Volume | |
| Avg. volume | 24,510,088 |
| Market cap | 182.616B |
| Beta (5Y monthly) | 0.98 |
| PE ratio (TTM) | 15.47 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.52 (3.50%) |
| Ex-dividend date | 05 Jul 2022 |
| 1y target est | N/A |
- GlobeNewswire
Cisco Senior Director of Enterprise Security Josephina Fernandez Joins Identity Defined Security Alliance Customer Advisory Board
Fernandez will join fellow IDSA members on upcoming panel to discuss best practices for implementing zero trustDENVER, May 03, 2022 (GLOBE NEWSWIRE) -- The Identity Defined Security Alliance (IDSA), a nonprofit that provides free vendor-neutral education and resources to help organizations reduce the risk of a breach by combining identity and security strategies, today announced that Josephina Fernandez, senior director of enterprise security for Cisco, has joined its Customer Advisory Board (CA
- Business Wire
Comcast Business Expands Managed Solutions Portfolio with Cisco SD-WAN
PHILADELPHIA, April 27, 2022--Comcast Business today announced the expansion of its strategic partnership with Cisco through the addition of Cisco SD-WAN powered by Viptela to its managed SD-WAN solutions portfolio. The collaboration expands Comcast Business’s ability to provide enterprise customers with comprehensive, global secure networking solutions with Ethernet, SD-WAN and security solutions – regardless of their existing infrastructure or vendor relationships.
- GlobeNewswire
Wesana Completes Filing of PCT Patents for Novel Drug Protocols
CHICAGO and TORONTO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company, is pleased to announce that it has filed Patent Cooperation Treaty (“PCT”) patent applications towards securing the exclusive rights to protocols, delivery methods and compositions of matter which includes utilizing a high loading dose of psilocybin-assisted psychotherapy, coupled with non-hallucinogenic, low maintenance do
